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Abstract. 
Background: Pandemic influenza A (H1N1) virus emerged and spread globally in the spring of 
2009. We  describe  the  clinical  features  of  the  patients  who  were  hospitalized  with  2009  H1N1 
influenza July 2009 to June 2010 in a tertiary care hospital in Khamis Mushyt, Saudi Arabia.
analyzed the clinical and laboratory variables in order to determine pred
Methods: We performed a prospective study in all patients who were hospitalized for at least 48 
hours and with a positive test for 2009 H1N1 virus through RT
reaction).  Their  epidemiological,  clinical
hospital  course  of  the  patients  with  eventual  outcome  (discharge  or  death)  was  observed.  We 
applied a logistic regression analysis to determine the best predictor of death.
Results: A total of 52 patients (15 males) were adults and 65 were pediatrics (< 12 years of age) (19 
males). The common presenting signs and/or symptoms associated with the disease was fever >38.5 
ºC (n=85; 72.6%), dry cough (n=81; 69.2%), dyspnea (n=40; 34.5%), tachycardia (n=96; 83.
and saturation less than 90% in room air on pulse oximetry (n=65; 55.6%).
included pneumonia (40.2 %), intensive care unit admission (19.2%) and death (16.7%).
Conclusions: We found that hypoxia at admission was the most important pr
outcome (death) with area under curve of 0.768
Introduction. During  the  spring  of  2009,  a  novel 
influenza  A  (H1N1)  virus  of  swine  origin  caused 
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Pandemic influenza A (H1N1) virus emerged and spread globally in the spring of 
We  describe  the  clinical  features  of  the  patients  who  were  hospitalized  with  2009  H1N1 
influenza July 2009 to June 2010 in a tertiary care hospital in Khamis Mushyt, Saudi Arabia.
analyzed the clinical and laboratory variables in order to determine predictors of poor outcome
We performed a prospective study in all patients who were hospitalized for at least 48 
and with a positive test for 2009 H1N1 virus through RT-PCR(real time polymerase chain 
reaction).  Their  epidemiological,  clinical,  biochemical  characteristics  were  collected  and  the 
hospital  course  of  the  patients  with  eventual  outcome  (discharge  or  death)  was  observed.  We 
applied a logistic regression analysis to determine the best predictor of death.
s (15 males) were adults and 65 were pediatrics (< 12 years of age) (19 
The common presenting signs and/or symptoms associated with the disease was fever >38.5 
ºC (n=85; 72.6%), dry cough (n=81; 69.2%), dyspnea (n=40; 34.5%), tachycardia (n=96; 83.
and saturation less than 90% in room air on pulse oximetry (n=65; 55.6%).
included pneumonia (40.2 %), intensive care unit admission (19.2%) and death (16.7%).
We found that hypoxia at admission was the most important pr
outcome (death) with area under curve of 0.768.
During  the  spring  of  2009,  a  novel 
influenza  A  (H1N1)  virus  of  swine  origin  caused 
human  infection  and  acute  respiratory  illness  in 
Mexico.
1,  2 After initially spreading across the United 
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
1 Influenza in a Tertiary Care 
, Mohammad Al-Hakami
1, Hassan 
Department of Internal Medicine, Armed Forces Hospital Southern Region, Khamis Mushyt, Saudi Arabia
Department of Preventive Medicine, Armed Forces Hospital Southern Region, Khamis Mushyt, Saudi Arabia
Department of Pediatrics, College Of Medicine, Najran University, Najran, Saudi Arabia
Armed Forces Hospital Southern 
adnanagha@hotmail.com
This  is  an  Open  Access  article  distributed  under  the  terms  of  the  Creative  Commons  Attribution  License
permits unrestricted use, distribution, and reproduction in any medium, 
Pandemic influenza A (H1N1) virus emerged and spread globally in the spring of 
We  describe  the  clinical  features  of  the  patients  who  were  hospitalized  with  2009  H1N1 
influenza July 2009 to June 2010 in a tertiary care hospital in Khamis Mushyt, Saudi Arabia. We 
ictors of poor outcome.
We performed a prospective study in all patients who were hospitalized for at least 48 
PCR(real time polymerase chain 
,  biochemical  characteristics  were  collected  and  the 
hospital  course  of  the  patients  with  eventual  outcome  (discharge  or  death)  was  observed.  We 
applied a logistic regression analysis to determine the best predictor of death.
s (15 males) were adults and 65 were pediatrics (< 12 years of age) (19 
The common presenting signs and/or symptoms associated with the disease was fever >38.5 
ºC (n=85; 72.6%), dry cough (n=81; 69.2%), dyspnea (n=40; 34.5%), tachycardia (n=96; 83.5%) 
and saturation less than 90% in room air on pulse oximetry (n=65; 55.6%). The complications 
included pneumonia (40.2 %), intensive care unit admission (19.2%) and death (16.7%).
We found that hypoxia at admission was the most important predictive factor of poor 
human  infection  and  acute  respiratory  illness  in 
After initially spreading across the United Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
States and Canada,
3 the virus spread globally, resulting 
in  the  first  influenza  pandemic  since  1968  with 
circulation  outside  the  usual  influenza  season in  the 
Northern Hemisphere.
4 As of March 2010, almost all 
countries  had  reported  cases,  and  more  than  17,700 
deaths  among  laboratory-confirmed  cases  had  been 
reported  to  the  World  Health  Organization  (WHO), 
which  significantly  underestimates  the  pandemic’s 
impact.
5 In the  United States alone, an estimated 59 
million illnesses, 265,000 hospitalizations, and 12,000 
deaths had been caused by the 2009 H1N1 virus as of 
February 2010, while in April 2010 WHO announced 
that H1N1 had entered a post-pandemic phase.
6
The  original  Pandemic  2009  H1N1  virus  genome 
actually derives six genes from triple-reassortant North 
American  swine  virus  lineages  and  two  genes  from 
Eurasian  swine  virus  lineages.
7 The  first  case  of 
pandemic influenza A (H1N1)  virus was reported in 
Saudi  Arabia  on  June  3,  2009.
8 On  September  12, 
2009, the Saudi Ministry of Health issued a national 
plan  for  the  management  of  the  flu-like  pandemics, 
specifically  pandemic  influenza  A  (H1N1)  virus 
infections.
9 Although  there  have  been  various  risk 
factors identified in recent literature from Saudi Arabia 
for  poor  outcome  among  patient  with  2009  H1N1 
infection, like delay in initiation of antiviral therapy, 
young  age  female  sex  and  patients  with  chest  pain, 
confusion or loss of consciousness;
10 but to-date there 
has been no study done to identify a model that could 
predict risk factor for poor outcome in these patients. 
Here  we  attempt  to  describe  the  clinical  and 
biochemical  features  of  the  patients  who  were 
hospitalized with 2009 H1N1 influenza July 2009 to 
June 2010 in a tertiary care hospital in Khamis Mushyt, 
in the southern region of Saudi Arabia and the hospital 
course  of  these  patients  outcome  and  the  predictive 
factors associated with poor outcome.
Patients and Methods. 
Study design: We performed a prospective study of all 
patients  who  were  admitted  to  Internal  Medicine  or 
Pediatric  Department, at  Armed  Forces  Hospital 
Southern Region Khamis Mushyt From July 3, 2009, to 
June 1, 2010.
Selection  of  patients: We  review  all  the  records  of 
hospitalized patients  that  had  at  least  48  hours  with 
influenza-like illness (temperature of 37.8°C or higher 
or  cough  or  sore  throat)  and  had  2009  H1N1  virus 
infection confirmed with RT-PCR at National Health 
Virology  Laboratory  in  Riyadh. The  RT-PCR  assay 
was performed using kits of the Centers for Disease 
Control  and  Prevention  (RT-PCR  protocol  for 
detection  and  characterization  of  swine  influenza, 
version 2009, CDC REF.#I-007-05).
11
We identified patients prospectively through daily 
reports  regarding  case-level  information  (including 
hospitalization  status)  from  departmental  reports  and 
authors  personally  collected  clinical  information  for 
each hospitalized patient after informed consent.
We  gathered  data  from  the  hospitalized  patients 
through  standardized  sheet  record  that  included 
demographic data, influenza-vaccination history for the 
previous year, underlying medical conditions, clinical 
signs  and  symptoms,  laboratory  tests,  radiographic 
findings, treatment course, requirement for ventilation 
or intensive care and eventual outcome. Specimens for 
bacterial infections were sent for all patients to rule out 
secondary infections. For time calculations, the day of 
admission  was  considered  to  be  hospital  day  0. The 
body-mass  index  (BMI,  the  weight  in  kilograms 
divided  by  the  square  of  the  height  in  meters)  was 
calculated,  for  patients  for  whom  height  and  weight 
were available, to determine whether the patient was 
obese (with obesity defined as a BMI of 29.9 or higher 
in adults 13 years of age or older or a BMI percentile 
of 95 to 100 in children between the ages of 2 and 12 
years) or morbidly obese (BMI ≥39.9 in adults only); 
the BMI was calculated in pregnant women based on 
their first antenatal visit in medical charts. Fever was 
defined as documented temperature of ≥37.5°C with 
high grade temperature being defined as documented 
temperature  of  ≥38.5°C.  Complicated  pandemic 
influenza was defined in the presence of radiologically 
confirmed pneumonia, septic shock, multiorgan failure, 
central  nervous  system  (CNS)  involvement,  etc.  or 
secondary bacterial infections of the upper respiratory 
tract  defined  and  diagnosed  by  standard  methods. A 
severe case was defined as requiring admission to an 
intensive  care  unit  (ICU)  or  death. We  performed 
separate analysis for patients who either died or were 
admitted  to  an  ICU. We  did  a  multivariate  logistic-
regression  analysis to  further  investigate associations 
with the severity of illness.
Results.
Clinical  features: A  total  of  52  patients  (15  males) 
were adults and 65 were pediatrics (19 males). There 
were 15 patients in the age group 60 years and above, 
35 patients in the age group 21-60 years, 18 patients in 
the  age group 6-20 years and 41 patients in  the age 
group 0-5 years (see table 1). The common presenting 
symptom associated with the disease was fever >38.5 
ºC  present in  85  cases  (72.6%), dry cough 81  cases 
(69.2%), dyspnea 40 cases (34.5%), vomiting 40 cases 
(34.2%)  and  diarrhea  45  cases  (38.8%). The  most 
significant signs associated with pandemic 2009 H1N1 
infection in our hospitalized patients were tachycardia 
present in 96 cases (83.5%), room air desaturation on 
pulse  oximetry  less  than  95%  present  in  65  cases 
(55.6%), tachypnea more than 20 breaths per minute Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table  1. Demographics  and  clinical  features  before  and  after 
admission in patient hospitalized with 2009 H1N1 infection.
Characteristics Demographics N %
Age
0 to 5 years old 41/117 41.9
6 to 20 years old 18/117 15.4
21 to 60 years old 35/117 29.9
> 60 years old 15/117 12.8
Gender. Female 60/117 51.3
Clinical Features Before Admission
Fever >38.5 ºC 85/117 72.6
Dry Cough 81/117 69.2
Cough with sputum 16/117 13.7
Myalgia 11/115 9.6
Headache 3/117 2.6
Rhinorrhea 21/117 21.4
Low grade of fever 7/109 6.4
Cyanosis 16/116 13.7
Dyspnea 40/116 34.5
Chest pain 9/116 7.8
Vomiting 40/117 34.2
Diarrhea 45/116 38.8
Clinical Features After Admission
Fever documented after admission 98/117 83.8
Pulse>100 beats per minute  96/115 83.5
Oxygen saturation values from pulse 
oximetry<95%
65/117 55.6
Cyanosis 19/115 16.5
Congested  throat 56/117 47.9
Lethargy 25/117 21.4
Crackle 57/116 49.1
Wheezing 10/117 17.1
Respiratory rates >20 breaths per minute 82/84 97.6
Respiratory distress 49/117 42.2
present  in  82  cases  (97.6%),  and  crackles  on  chest 
auscultation present in 57 cases (49.1%) (see table 1
for details).
Co-morbidities: There  were  10  patients  who  were 
pregnant  (10.5%)  and  the  common  co-morbidities 
among  the  all  patients  hospitalized  with  H1N1 
pandemic  were  chronic  kidney  disease  present  in  5 
cases (4.3 %),  Sickle cell anemia present  in  8 cases 
(6.9%), Congenital cardiovascular disease present in 5 
cases (4.3%), Asthma present in  7 cases (6.8%) and 
Epilepsy present in 11 cases (9.5%).
Radiological and  Laboratory  Findings: Most  of the 
patient  hospitalized  with  2009  H1N1  infection  had
Table 2. Co-morbidities in patient hospitalized with 2009 H1N1 
infection.
Comorbidity N %
Kaposi Sarcoma 2/116 1.7
Type I Diabetes Mellitus 1/116 0.9
Pregnant women 10/95 10.5
Chronic Kidney Disease  5/116 4.3
Sickle cell anemia 8/116 6.9
Congenital cardiovascular disease 5/116 4.3
Asthma 7/116 6.8
Type II Diabetes Mellitus 4/103 3.9
Epilepsy 11/116 9.5
Hepatitis B 1/116 0.9
Immunosuppressive drugs 2/104 1.9
right  sided  infiltrates  on  chest  x-ray  in  24  cases 
(20.5%) and normal chest x-ray in 28 patients (41.0%).
Arterial blood gases showed hypoxia in 47 patients 
(56.6%),  while  blood  work  showed  anemia  in  36 
patients (30.8%), normal white blood count in 82 cases 
(70.1%), low white blood count in 11 patients (9.4%), 
raised alanine transaminase in 19 patients (16.8%)
Morbidity: The patients hospitalized with 2009 H1N1 
infection had complications like requiring non-invasive 
ventilation in 4 patient (3.4%) and invasive mechanical 
ventilation in 16 cases (13.7%). The mortality in our 
patients was 18 cases (16.7%).
Pregnancy: A total of 10 patients who were pregnant 
(10.5 %), there were 0 deaths among pregnant patients 
and the mortality was slightly better when compared to 
the total population mortality of 16.7%.
Predictive  Model:  We  tried  to  identify  the  factors 
predicting the poor outcome in the patient hospitalized 
with  2009  H1N1  infection. The  important  factors 
associated with morbidity and mortality were need for 
non-invasive  mechanical  ventilation  (n=4),  invasive 
mechanical  ventilation  (n=16),  type  2  respiratory 
failure (n=7), bilateral chest infiltrates (n=11) and low 
white blood cell count (n=11) but the small number of 
patients did not allow to do more stratified analysis.
The  logistic  regression  analysis  showed  that  the 
hypoxia  at  admission  is  the  most  important  variable 
(n=65) after adjusted by duration of symptoms, age and 
sex, the model has an area under the curve being 0.768.
Predictive Model=Log P (dead)-3.03+1.85* 
Hypoxia +0.10 * Days of onset of symptoms +0.006 *
Age+0.91*sex  (see figure 1).
Discussion.  In  this  study,  we  have  shown  that 
pandemic influenza caused considerable morbidity in a 
significant  proportion  of  hospitalized  adults  and  that 
the use of antiviral drugs was beneficial in hospitalized 
patients. The distribution of influenza A (H1N1) cases Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table 3. Pertinent investigations in patient hospitalized with 2009 
H1N1 infection.
Investigation N %age
Left sided infiltrates on chest x-ray 9/117 7.7
Right sided infiltrates on chest x-ray 24/117 20.5
Diffuse multilobar infiltrates on chest x-ray 9/117 7.7
Scattered bilateral infiltrates on chest x-ray 15/117 12.8
Normal chest x-ray 48/117 41.0
Hypoxia on arterial blood gases 47/83 56.6
Type II respiratory failure on arterial blood 
gases
7/83 8.5
Normal arterial blood gases 29/83 34.9
Hemoglobin  (Anemia:  Adult  Male    <14  
gm/dl    and  Adult  Female  <13  gm/dl; 
children <11 gm/dl)
36/117 30.8
Platelets < 140 x 109 /ul 18/117 15.4
Platelets 140 to 400 x 109/ul  87/117 74.3
Platelets > 400 x 109/ul 12/117 10.3
White Blood Cell Count < 4  x 109/ul 11/117 9.4
White Blood Cell Count 4 to 11 x 109/ul 82/117 70.1
White Blood Cell Count > 11 x 109/ul 24/117 20.5
Total Bilirubin 3 to 17 umol/L 69/108 63.9
Total Bilirubin > 17 umol/L 39/108 36.1
Alanine transaminase (ALT)< 30 U/L 51/113 45.1
Alanine transaminase (ALT) 30 to 65 U/L 43/113 38.1
Alanine transaminase (ALT) > 65 U/L 19/113 16.8
Creatine kinase (CK) 21 to 232 U/L 65/111 58.6
Creatine kinase (CK) > 232 U/L 46/111 41.4
Lactate  dehydrogenase (LDH)  100  to  500 
U/L
105/117 89.7
Lactate dehydrogenase (LDH) > 500 U/L 12/117 10.3
Urea 2.5 to 7.5 mmol/L 79/117 67.5
Urea > 7.5 mmol/L 25/117 21.4
by age was similar to the distribution of cases observed 
worldwide, suggesting the possibility of varying levels 
of  immunity in  the  young  age  group although  more 
than 90% of influenza-related deaths occur in patients 
in  the  older  age  group.
12 Underlying  medical 
conditions  that  have  been  reported  in  patients 
worldwide  who  were  hospitalized  with  seasonal 
influenza  have  included  diabetes  and  cardiovascular, 
neurologic,  and  pulmonary  diseases,  including 
asthma.
13 Frequently  reported  complications  have 
included  pneumonia,  bacterial  coinfection,  and 
exacerbation of underlying medical conditions, such as 
congestive heart failure.
14
Our  study  summarizes  the  clinical  findings 
regarding patients who were hospitalized for the 
Table 4. Complications  in  patient  hospitalized  with 2009  H1N1 
infection.
Complication N %age
CPAP* 2/117 1.7
CPAP then intubated 2/117 1.7
Intubated 16/117 13.7
None 97/117 82.9
Duration  of  stay  in 
days; Median 
4*
2-7 days; Median, 
(1
st-3
rd Quantile)
Complications 20/104 19.2
Dead 18/108 16.7
*CPAP= Continuous positive airway pressure ventilation.
treatment of 2009 H1N1 influenza in pandemic period 
over one year. Studies have shown that early therapy 
with  oseltamivir  in  patients  with  2009  H1N1  virus 
infection  may  reduce  the  duration  of  hospitalization 
and the risk of progression to severe disease requiring 
ICU admission or resulting in death.
15,16,17 Studies have 
also  shown  that  patients  with  immunosuppressant 
states such as cancer and/or stem cell transplantation 
who develop 2009 H1N1 have not been associated with 
more poor outcome.
18 International studies have shown 
that In-hospital mortality was higher in patients with 
pneumonia than in the others (5.2% vs. 0%; p < 0.001) 
while the absence of comorbid conditions (odds ratio 
[OR], 2.07; 95% confidence interval [CI], 1.32-3.24) 
was  found  to  be  an  independent  risk  factor  for 
pneumonia, whereas early (≤48 h) oseltamivir therapy 
(OR,  0.29;  95%  CI,  0.19-0.46)  was  a  protective 
factor.
19
When  compared  to  the  local  studies  in  Saudi 
Arabia, risk factor associated with severe 2009 H1N1 
infection leading to  either complications or intensive 
care admission have been delay in initiation of antiviral 
therapy,  history  of  opium  inhalation,  younger  age 
group and in female dependents and certain symptoms 
like;  productive  cough,  hemoptysis,  chest  pain, 
confusion, loss of consciousness.
20, 21
In our study involving 117 patients with 2009 H1N1 
virus  40.2%  had  pneumonia  on  chest  x-ray,  19.2% 
required  mechanical  ventilation  and  16.7%  died;  all 
patients  received  oseltamivir. The  factor  most 
predictive of morbidity and mortality was hypoxia at 
admission that had an area under curve of 0.768 with 
OR for hypoxia being 6.356 with 95% CI being 1.16-
34.55. Although the number of patients in this study 
was small and it was single centered experience, we 
may  identify  patient  at  high  risk  for  morbidity  and 
mortality using this model.
Conclusion. During the evaluation period, 2009 H1N1 
influenza  caused  severe  illness  including  pneumonia 
(40.2 %), intensive care unit admission (19.2%) and Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Figure 1. Predictive model for predicting poor outcome in patients hospitalized with 2009 h1n1 pandemic 
death  (16.7%)  in  single  tertiary  care  hospital  in  the 
southern region of Saudi Arabia over a one year period.
The most significant factor in our small study that was 
predictive of morbidity and mortality in  our patients 
was hypoxia at admission that had an area under curve 
of 0.768 (see figure 1). Identifying the patients with 
hypoxia  in  suspected cases  of  2009  H1N1  influenza 
infection is therefore prudent as these patients may be 
at greater risk for morbidity and mortality. Although 
2009 H1N1 infection is now considered to be in post-
pandemic  phase with  low  virological  activity, 
identifying risk factors such as hypoxia on presentation 
in  these  patients  may  still  be  necessary  to  optimize 
treatment  strategies  and  therefore  further  studies  to 
needed  identify/confirm  the  factors  predicting  poor 
outcomes in  patients  admitted  with  2009  H1N1 
infection.
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